IC
PBLA

Ikarian Capital’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Ikarian Capital’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed -$750K – 246
2022
Q1 		$750K Buy
15
+1
+7% +$46.1K 0.23% 110
2021
Q4 		$592K Hold
14
– – 0.17% 120
2021
Q3 		$734K Hold
14
– – 0.17% 172
2021
Q2 		$976K Hold
14
– – 0.17% 162
2021
Q1 		$1.36M Buy
+14
New +$1.58M 0.2% 226

Other funds holding PBLA

BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return